Duration of Apixaban Thromboprophylaxis in Spinal Fracture Patients
For patients with spinal fractures requiring thromboprophylaxis, apixaban 2.5 mg twice daily should be administered for approximately 3 months (12 weeks) post-injury, with initiation timing dependent on surgical intervention and bleeding risk.
Timing of Initiation
Post-Surgical Patients
For patients undergoing operative fixation of spine fractures, the evidence supports initiating chemoprophylaxis within 48-72 hours after surgery 1. Specifically:
- High bleeding risk surgery (which spine surgery typically represents): Resume apixaban 2.5 mg twice daily at 48-72 hours postoperatively 1
- Recent evidence demonstrates that initiation at 72 hours post-fixation decreases VTE events without increasing bleeding complications 2
- Earlier initiation (<48 hours) appears safe but should be reserved for patients at particularly high thrombotic risk 3
Non-Surgical or Delayed Surgery Patients
For patients with spinal cord injury (SCI) awaiting delayed surgery or managed non-operatively, initiate pharmacologic thromboprophylaxis as soon as possible, ideally within 72 hours of injury 4, 5.
Duration of Treatment
The optimal duration is 3 months (approximately 12 weeks) post-injury 4. This recommendation is based on:
- Consensus among spine trauma surgeons that 3 months represents the period of highest VTE risk 4
- Evidence that the highest incidence of VTE occurs in the acute period, particularly in thoracic segment injuries 6
- Standard practice for extended thromboprophylaxis in high-risk orthopedic trauma 7, 8
Dosing Specifics
The 2.5 mg twice daily dose is appropriate for thromboprophylaxis in this setting 1. This is the prophylactic dose used post-orthopedic surgery, distinct from:
- Treatment doses (10 mg twice daily for 7 days, then 5 mg twice daily) 9
- Extended secondary prevention doses (2.5 mg twice daily after completing initial treatment) 10, 9
Risk Stratification Considerations
Higher-risk patients requiring particular attention include:
- Age ≥45 years (5-fold increased VTE risk) 3
- Concomitant traumatic brain injury (7-fold increased VTE risk) 3
- Thoracic segment spinal cord injuries 6, 4
- Complete spinal cord injuries
- Patients with delayed mobilization
Critical Caveats
Contraindications to Early Initiation
Delay or withhold apixaban if:
- Active pathological bleeding 9
- Epidural hematoma risk (particularly with indwelling epidural catheters) 9
- Concomitant intracranial hemorrhage or intraspinal bleeding 2
- Inadequate hemostasis post-surgery 1
Monitoring Requirements
While on apixaban:
- Monitor for signs of bleeding complications
- Assess neurological status frequently, especially in the first 48-72 hours post-surgery 9
- Consider mechanical prophylaxis (compression devices) as adjunct therapy 8, 6
Drug Interactions
Avoid or adjust dosing with combined P-glycoprotein and strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir) 9. In patients already on 2.5 mg twice daily, avoid these combinations entirely 9.
Alternative Approach for Very High-Risk Patients
For patients at exceptionally high VTE risk who cannot wait 48-72 hours post-surgery, consider:
- Mechanical prophylaxis immediately postoperatively
- Low molecular weight heparin (LMWH) at prophylactic doses starting 12-24 hours post-surgery 8
- Transition to apixaban once bleeding risk stabilizes
The evidence strongly supports that waiting 72 hours post-operatively to initiate apixaban 2.5 mg twice daily, then continuing for 3 months total, optimally balances VTE prevention against bleeding risk in spinal fracture patients 4, 2, 5.